Instem – executive interview

Published on 19 May 2021

Instem’s CEO, Phil Reason, discusses how the business’s solutions help optimise R&D processes in the life sciences industry and explains the company’s value proposition in each of its segments: Study Management, Regulatory Solutions, In Silico Solutions and Clinical Trial Acceleration Solutions. He discusses the market landscape for software solutions in life sciences and the company’s M&A strategy, before explaining how the company’s two most recent acquisitions, The Edge and d-wise, fit in with this. He finishes by discussing his expectations for organic growth in the future.

Instem is a leading provider of IT solutions and services to the life sciences market.

Share this with friends and colleagues